-
1
-
-
84867046103
-
Colistin: an update on the antibiotic of the 21st century
-
Biswas S., Brunel J.M., Dubus J.C., Reynaud-Gaubert M., Rolain J.M. Colistin: an update on the antibiotic of the 21st century. Expert Rev Anti Infect Ther 2012, 10:917-934.
-
(2012)
Expert Rev Anti Infect Ther
, vol.10
, pp. 917-934
-
-
Biswas, S.1
Brunel, J.M.2
Dubus, J.C.3
Reynaud-Gaubert, M.4
Rolain, J.M.5
-
2
-
-
77957951965
-
Resistance to polymyxins: mechanisms, frequency and treatment options
-
Falagas M.E., Rafailidis P.I., Matthaiou D.K. Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist Updat 2010, 13:132-138.
-
(2010)
Drug Resist Updat
, vol.13
, pp. 132-138
-
-
Falagas, M.E.1
Rafailidis, P.I.2
Matthaiou, D.K.3
-
3
-
-
84926489004
-
The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae
-
Poirel L., Jayol A., Bontron S., et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 2015, 70:75-80.
-
(2015)
J Antimicrob Chemother
, vol.70
, pp. 75-80
-
-
Poirel, L.1
Jayol, A.2
Bontron, S.3
-
4
-
-
84905399119
-
Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin
-
Jayol A., Poirel L., Brink A., Villegas M.V., Yilmaz M., Nordmann P. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob Agents Chemother 2014, 58:4762-4766.
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 4762-4766
-
-
Jayol, A.1
Poirel, L.2
Brink, A.3
Villegas, M.V.4
Yilmaz, M.5
Nordmann, P.6
-
5
-
-
84885909781
-
In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator
-
Cannatelli A., D'Andrea M.M., Giani T., et al. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother 2013, 57:5521-5526.
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 5521-5526
-
-
Cannatelli, A.1
D'Andrea, M.M.2
Giani, T.3
-
6
-
-
84905394181
-
In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment
-
Cannatelli A., Di Pilato V., Giani T., et al. In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment. Antimicrob Agents Chemother 2014, 58:4399-4403.
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 4399-4403
-
-
Cannatelli, A.1
Di Pilato, V.2
Giani, T.3
-
7
-
-
84921029928
-
Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12)
-
Sader H.S., Farrell D.J., Castanheira M., Flamm R.K., Jones R.N. Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12). J Antimicrob Chemother 2014, 69:2713-2722.
-
(2014)
J Antimicrob Chemother
, vol.69
, pp. 2713-2722
-
-
Sader, H.S.1
Farrell, D.J.2
Castanheira, M.3
Flamm, R.K.4
Jones, R.N.5
-
9
-
-
84878469949
-
Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011
-
Giani T., Pini B., Arena F., et al. Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011. Euro Surveill 2013, 18:20489.
-
(2013)
Euro Surveill
, vol.18
, pp. 20489
-
-
Giani, T.1
Pini, B.2
Arena, F.3
-
10
-
-
84899545436
-
Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates
-
Pena I., Picazo J.J., Rodríguez-Avial C., Rodríguez-Avial I. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates. Int J Antimicrob Agents 2014, 43:460-464.
-
(2014)
Int J Antimicrob Agents
, vol.43
, pp. 460-464
-
-
Pena, I.1
Picazo, J.J.2
Rodríguez-Avial, C.3
Rodríguez-Avial, I.4
-
11
-
-
0021189968
-
Affinity of temocillin for Escherichia coli K-12 penicillin-binding proteins
-
Labia R., Baron P., Masson J.M., Hill G., Cole M. Affinity of temocillin for Escherichia coli K-12 penicillin-binding proteins. Antimicrob Agents Chemother 1984, 26:335-338.
-
(1984)
Antimicrob Agents Chemother
, vol.26
, pp. 335-338
-
-
Labia, R.1
Baron, P.2
Masson, J.M.3
Hill, G.4
Cole, M.5
-
13
-
-
38449088541
-
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection
-
De Jongh R., Hens R., Basma V., Mouton J.W., Tulkens P.M., Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008, 61:382-388.
-
(2008)
J Antimicrob Chemother
, vol.61
, pp. 382-388
-
-
De Jongh, R.1
Hens, R.2
Basma, V.3
Mouton, J.W.4
Tulkens, P.M.5
Carryn, S.6
-
14
-
-
33645120482
-
In vitro activity of temocillin against extended spectrum β-lactamase-producing Escherichia coli
-
Rodriguez-Villalobos H., Malaviolle V., Frankard J., de Mendonça R., Nonhoff C., Struelens M.J. In vitro activity of temocillin against extended spectrum β-lactamase-producing Escherichia coli. J Antimicrob Chemother 2006, 57:771-774.
-
(2006)
J Antimicrob Chemother
, vol.57
, pp. 771-774
-
-
Rodriguez-Villalobos, H.1
Malaviolle, V.2
Frankard, J.3
de Mendonça, R.4
Nonhoff, C.5
Struelens, M.J.6
-
15
-
-
35348819978
-
In vitro activity of temocillin against prevalent extended-spectrum β-lactamases producing Enterobacteriaceae from Belgian intensive care units
-
Glupczynski Y., Huang T.D., Berhin C., et al. In vitro activity of temocillin against prevalent extended-spectrum β-lactamases producing Enterobacteriaceae from Belgian intensive care units. Eur J Clin Microbiol Infect Dis 2007, 26:777-783.
-
(2007)
Eur J Clin Microbiol Infect Dis
, vol.26
, pp. 777-783
-
-
Glupczynski, Y.1
Huang, T.D.2
Berhin, C.3
-
16
-
-
33645836294
-
Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England
-
Livermore D.M., Hope R., Fagan E.J., Warner M., Woodford N., Potz N. Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England. J Antimicrob Chemother 2006, 57:1012-1014.
-
(2006)
J Antimicrob Chemother
, vol.57
, pp. 1012-1014
-
-
Livermore, D.M.1
Hope, R.2
Fagan, E.J.3
Warner, M.4
Woodford, N.5
Potz, N.6
-
17
-
-
84910023053
-
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea
-
Seo M.R., Kim S.J., Kim Y., et al. Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea. J Korean Med Sci 2014, 29:1178-1181.
-
(2014)
J Korean Med Sci
, vol.29
, pp. 1178-1181
-
-
Seo, M.R.1
Kim, S.J.2
Kim, Y.3
-
18
-
-
81355149261
-
Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae
-
Titelman E., Iversen A., Kahlmeter G., Giske C.G. Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae. APMIS 2011, 119:853-863.
-
(2011)
APMIS
, vol.119
, pp. 853-863
-
-
Titelman, E.1
Iversen, A.2
Kahlmeter, G.3
Giske, C.G.4
-
19
-
-
80051546373
-
In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli
-
Tärnberg M., Ostholm-Balkhed A., Monstein H.J., Hällgren A., Hanberger H., Nilsson L.E. In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli. Eur J Clin Microbiol Infect Dis 2011, 30:981-987.
-
(2011)
Eur J Clin Microbiol Infect Dis
, vol.30
, pp. 981-987
-
-
Tärnberg, M.1
Ostholm-Balkhed, A.2
Monstein, H.J.3
Hällgren, A.4
Hanberger, H.5
Nilsson, L.E.6
-
20
-
-
84892471881
-
In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase
-
Woodford N., Pike R., Meunier D., Loy R., Hill R., Hopkins K.L. In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase. J Antimicrob Chemother 2014, 69:564-567.
-
(2014)
J Antimicrob Chemother
, vol.69
, pp. 564-567
-
-
Woodford, N.1
Pike, R.2
Meunier, D.3
Loy, R.4
Hill, R.5
Hopkins, K.L.6
-
21
-
-
84892470726
-
Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers
-
Huang T.D., Poirel L., Bogaerts P., Berhin C., Nordmann P., Glupczynski Y. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers. J Antimicrob Chemother 2014, 69:445-450.
-
(2014)
J Antimicrob Chemother
, vol.69
, pp. 445-450
-
-
Huang, T.D.1
Poirel, L.2
Bogaerts, P.3
Berhin, C.4
Nordmann, P.5
Glupczynski, Y.6
-
22
-
-
84902209071
-
Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance
-
Castañeda-García A., Blázquez J., Rodríguez-Rojas A. Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance. Antibiotics 2013, 2:217-236.
-
(2013)
Antibiotics
, vol.2
, pp. 217-236
-
-
Castañeda-García, A.1
Blázquez, J.2
Rodríguez-Rojas, A.3
-
23
-
-
84929574307
-
Working Party 'Antimicrobial Resistance' of the Paul-Ehrlich-Society for Chemotherapy. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin
-
Kresken M., Pfeifer Y., Hafner D., Wresch R., Körber-Irrgang B. Working Party 'Antimicrobial Resistance' of the Paul-Ehrlich-Society for Chemotherapy. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin. Int J Antimicrob Agents 2014, 44:295-300.
-
(2014)
Int J Antimicrob Agents
, vol.44
, pp. 295-300
-
-
Kresken, M.1
Pfeifer, Y.2
Hafner, D.3
Wresch, R.4
Körber-Irrgang, B.5
-
24
-
-
84901649592
-
Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany
-
Kaase M., Szabados F., Anders A., Gatermann S.G. Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany. J Clin Microbiol 2014, 52:1893-1897.
-
(2014)
J Clin Microbiol
, vol.52
, pp. 1893-1897
-
-
Kaase, M.1
Szabados, F.2
Anders, A.3
Gatermann, S.G.4
-
25
-
-
84893169017
-
In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004-2012)
-
Lai B., Zheng B., Li Y., Zhu S., Tong Z. In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004-2012). BMC Infect Dis 2014, 14:66.
-
(2014)
BMC Infect Dis
, vol.14
, pp. 66
-
-
Lai, B.1
Zheng, B.2
Li, Y.3
Zhu, S.4
Tong, Z.5
-
26
-
-
84908152273
-
Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: a 7-year surveillance study
-
Sorlozano A., Jimenez-Pacheco A., de Dios Luna Del Castillo J., et al. Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: a 7-year surveillance study. Am J Infect Control 2014, 42:1033-1038.
-
(2014)
Am J Infect Control
, vol.42
, pp. 1033-1038
-
-
Sorlozano, A.1
Jimenez-Pacheco, A.2
de Dios Luna Del Castillo, J.3
-
27
-
-
84906078362
-
Clonal diversity of Escherichia coli isolates carrying plasmid-mediated fosfomycin resistance gene fosA3 from livestock and other animals
-
Chan J., Lo W.U., Chow K.H., Lai E.L., Law P.Y., Ho P.L. Clonal diversity of Escherichia coli isolates carrying plasmid-mediated fosfomycin resistance gene fosA3 from livestock and other animals. Antimicrob Agents Chemother 2014, 58:5638-5639.
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 5638-5639
-
-
Chan, J.1
Lo, W.U.2
Chow, K.H.3
Lai, E.L.4
Law, P.Y.5
Ho, P.L.6
-
28
-
-
0033833440
-
Pivmecillinam in the treatment of urinary tract infections
-
Nicolle L.E. Pivmecillinam in the treatment of urinary tract infections. J Antimicrob Chemother 2000, 46(Suppl. 1):35-39.
-
(2000)
J Antimicrob Chemother
, vol.46
, pp. 35-39
-
-
Nicolle, L.E.1
-
29
-
-
1642422921
-
Urinary concentrations and urine ex-vivo effect of mecillinam and sulphamethizole
-
Kerrn M.B., Frimodt-Møller N., Espersen F. Urinary concentrations and urine ex-vivo effect of mecillinam and sulphamethizole. Clin Microbiol Infect 2004, 10:54-61.
-
(2004)
Clin Microbiol Infect
, vol.10
, pp. 54-61
-
-
Kerrn, M.B.1
Frimodt-Møller, N.2
Espersen, F.3
-
30
-
-
0035468838
-
Effect of antimicrobial agents on the ecological balance of human microflora
-
Sullivan Å., Edlund C., Nord C.E. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001, 1:101-114.
-
(2001)
Lancet Infect Dis
, vol.1
, pp. 101-114
-
-
Sullivan, Å.1
Edlund, C.2
Nord, C.E.3
-
31
-
-
0017683098
-
The mechanism of action of mecillinam
-
Spratt B.G. The mechanism of action of mecillinam. J Antimicrob Chemother 1977, 3:13-19.
-
(1977)
J Antimicrob Chemother
, vol.3
, pp. 13-19
-
-
Spratt, B.G.1
-
32
-
-
0013096299
-
Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12
-
Spratt B.G. Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12. Proc Natl Acad Sci U S A 1975, 72:2999-3003.
-
(1975)
Proc Natl Acad Sci U S A
, vol.72
, pp. 2999-3003
-
-
Spratt, B.G.1
-
33
-
-
84894088675
-
Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections
-
Jansåker F., Frimodt-Møller N., Sjögren I., Dahl Knudsen J. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections. J Antimicrob Chemother 2014, 69:769-772.
-
(2014)
J Antimicrob Chemother
, vol.69
, pp. 769-772
-
-
Jansåker, F.1
Frimodt-Møller, N.2
Sjögren, I.3
Dahl Knudsen, J.4
-
34
-
-
84859619515
-
Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
-
Titelman E., Iversen A., Kalin M., Giske C.G. Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Microb Drug Resist 2012, 18:189-192.
-
(2012)
Microb Drug Resist
, vol.18
, pp. 189-192
-
-
Titelman, E.1
Iversen, A.2
Kalin, M.3
Giske, C.G.4
-
35
-
-
84898629855
-
High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli
-
Søraas A., Sundsfjord A., Jørgensen S.B., Liestøl K., Jenum P.A. High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli. PLoS One 2014, 9:e85889.
-
(2014)
PLoS One
, vol.9
, pp. e85889
-
-
Søraas, A.1
Sundsfjord, A.2
Jørgensen, S.B.3
Liestøl, K.4
Jenum, P.A.5
-
36
-
-
0033824888
-
Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases
-
Sougakoff W., Jarlier V. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases. J Antimicrob Chemother 2000, 46(Suppl. A):9-14.
-
(2000)
J Antimicrob Chemother
, vol.46
, pp. 9-14
-
-
Sougakoff, W.1
Jarlier, V.2
-
37
-
-
84937694499
-
In vitro activity of mecillinam against Enterobacteriaceae with NDM-1 carbapenemase
-
Marrs E.C., Day K.M., Perry J.D. In vitro activity of mecillinam against Enterobacteriaceae with NDM-1 carbapenemase. J Antimicrob Chemother 2014, 69:2873-2875.
-
(2014)
J Antimicrob Chemother
, vol.69
, pp. 2873-2875
-
-
Marrs, E.C.1
Day, K.M.2
Perry, J.D.3
-
38
-
-
84923250957
-
Amdinocillin (mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli
-
Thulin E., Sundqvist M., Andersson D.I. Amdinocillin (mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli. Antimicrob Agents Chemother 2015, 59:1718-1727.
-
(2015)
Antimicrob Agents Chemother
, vol.59
, pp. 1718-1727
-
-
Thulin, E.1
Sundqvist, M.2
Andersson, D.I.3
-
39
-
-
0141758347
-
Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO-SENS study
-
Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO-SENS study. Int J Antimicrob Agents 2003, 22(Suppl. 2):49-52.
-
(2003)
Int J Antimicrob Agents
, vol.22
, pp. 49-52
-
-
Kahlmeter, G.1
-
40
-
-
82955187565
-
Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO-SENS study revisited
-
Kahlmeter G., Poulsen H.O. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO-SENS study revisited. Int J Antimicrob Agents 2012, 39:45-51.
-
(2012)
Int J Antimicrob Agents
, vol.39
, pp. 45-51
-
-
Kahlmeter, G.1
Poulsen, H.O.2
-
42
-
-
77950353740
-
Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins
-
Wootton M., Walsh T.R., Macfarlane L., Howe R.A. Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother 2010, 65:79-81.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 79-81
-
-
Wootton, M.1
Walsh, T.R.2
Macfarlane, L.3
Howe, R.A.4
-
43
-
-
49649095454
-
Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli
-
Sandegren L., Lindqvist A., Kahlmeter G., Andersson D.I. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J Antimicrob Chemother 2008, 62:495-503.
-
(2008)
J Antimicrob Chemother
, vol.62
, pp. 495-503
-
-
Sandegren, L.1
Lindqvist, A.2
Kahlmeter, G.3
Andersson, D.I.4
-
44
-
-
0017833324
-
The pharmacokinetics of nitrofurantoin and its related bioavailability
-
Conklin J.D. The pharmacokinetics of nitrofurantoin and its related bioavailability. Antibiot Chemother 1978, 25:233-252.
-
(1978)
Antibiot Chemother
, vol.25
, pp. 233-252
-
-
Conklin, J.D.1
-
45
-
-
84936932880
-
Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota
-
In press
-
Vervoort J., Xavier B.B., Stewardson A., et al. Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota. J Antimicrob Chemother 2015, In press.
-
(2015)
J Antimicrob Chemother
-
-
Vervoort, J.1
Xavier, B.B.2
Stewardson, A.3
-
46
-
-
84912533203
-
An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli
-
Vervoort J., Xavier B.B., Stewardson A., et al. An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli. Antimicrob Agents Chemother 2014, 58:7225-7233.
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 7225-7233
-
-
Vervoort, J.1
Xavier, B.B.2
Stewardson, A.3
-
47
-
-
0028285474
-
Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens
-
McOsker C.C., Fitzpatrick P.M. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother 1994, 33(Suppl. A):23-30.
-
(1994)
J Antimicrob Chemother
, vol.33
, pp. 23-30
-
-
McOsker, C.C.1
Fitzpatrick, P.M.2
|